European Animal Research Association

05/06/2026

Researchers from EARA member University of Toronto and McGill University have identified a brain circuit in mice that causes negative experiences to amplify pain, which could help develop better therapies to reduce pain.

Learn more: https://www.eara.eu/news/why-negative-expectations-make-pain-worse-study-in-mice

05/06/2026

An article on The Transmitter featured an awareness campaign launched by the group Oregon Voices for Biomedical Research, alerting the public to the impact that the closure of the Oregon National Primate Research Center (ONPRC) could have on biomedical research, amid negotiations to transform the facility into an animal sanctuary.

Learn more: https://www.eara.eu/news/oregon-researchers-advocate-for-primate-research

Researchers in the US have launched an awareness campaign on billboards, buses across Oregon and social media, alerting the public to the impact that the closure of the Oregon National Primate Research Center (ONPRC) could have on biomedical research, amid negotiations to transform the facility into...

04/06/2026

Researchers from the Université de Genève have transplanted, into diabetic mice, a graft with insulin-producing cells and endothelial cells that can restore long-term blood sugar control, offering a potential strategy to improve cell-based therapies for type 1 diabetes.

Learn more: https://www.eara.eu/news/cell-transplant-restores-insulin-production-in-diabetic-mice

Researchers in Switzerland have transplanted, into diabetic mice, a graft with insulin-producing cells and endothelial cells that can restore long-term blood sugar control, offering a potential strategy to improve cell-based therapies for type 1 diabetes. Type 1 diabetes occurs when the immune syste...

03/06/2026

A Patient Discovery Day focused on cerebrovascular diseases and stroke recovery was held in Madrid, bringing together stroke survivors and patient association representatives with research teams working to develop new therapeutic strategies for these conditions.

The event was organised by EARA in collaboration with the Instituto de Investigación Biosanitaria Hospital Universitario 12 de Octubre (imas12) and the EARA member Universidad Complutense de Madrid (UCM). The initiative also involved researchers from the RICORS ICTUS network, funded by the Instituto de Salud Carlos III (ISCIII), which promotes collaborative research into stroke and cerebrovascular diseases across Spain.

Read more: https://www.eara.eu/press-releases/stroke-survivors-and-scientists-come-together-at-eara-patient-discovery-day-in-madrid

A Patient Discovery Day focused on cerebrovascular diseases and stroke recovery was held in Madrid, bringing together stroke survivors and patient association representatives with research teams working to develop new therapeutic strategies for these conditions. The event was organised by the Europe...

01/06/2026

PrimeMeet Europe, held last week in the Netherlands, brought together representatives from primate centres, academia, industry, breeding companies and research organisations to discuss the future of non-human primate (NHP) research in Europe and strengthen collaboration across the field.

Learn more: https://www.eara.eu/news/primemeet-europe-strengthens-collaboration-in-nhp-research

PrimeMeet Europe, held on 26-27 May in Haarlem, the Netherlands, brought together representatives from primate centres, academia, industry, breeding companies and research organisations to discuss the future of non-human primate (NHP) research in Europe and strengthen collaboration across the field....

29/05/2026

Researchers at EARA member Max Delbrück Center have shown that inflammation helps zebrafish regenerate their hearts after injury, offering insights that could contribute to the development of new therapies for heart repair.

Learn more: https://www.eara.eu/news/immune-cells-kickstart-heart-repair-in-zebrafish

Researchers in Germany have shown that inflammation helps zebrafish regenerate their hearts after injury, offering insights that could contribute to the development of new therapies for heart repair. After a heart attack, the damaged tissue is replaced by stiff scar tissue, reducing the heart’s ab...

28/05/2026

Researchers from RMIT University, Adelaide University and EARA member Trinity College Dublin, have uncovered why, in pregnant mice, the flu can be more dangerous during pregnancy, identifying an immune sensor that becomes overactive and triggers harmful inflammation.

Learn more: https://www.eara.eu/news/severe-flu-during-pregnancy-linked-to-immune-sensor-mice-study

Researchers in Australia and Ireland have uncovered why, in pregnant mice, the flu can be more dangerous during pregnancy, identifying an immune sensor that becomes overactive and triggers harmful inflammation. In most people with flu, the virus remains in the upper respiratory tract — mainly the ...

27/05/2026

Researchers from Goethe-Universität Frankfurt, an EARA member, have developed an artificial intelligence (AI) tool that can learn from data obtained from animal studies and generate additional data, potentially reducing the number of animals needed in research.

Learn more: https://www.eara.eu/news/ai-could-reduce-number-of-animals-needed-in-preclinical-studies

Researchers in Germany have developed an artificial intelligence (AI) tool, called genESOM, that can learn from data obtained from animal studies and generate additional data, potentially reducing the number of animals needed in research. In early drug development, researchers aim to keep the number...

26/05/2026

Researchers at Georgetown’s Lombardi Comprehensive Cancer Center, using mice and data from patients, have identified a protein involved in the spread of breast cancer to other organs— metastasis — in older individuals, which is responsible for most deaths due to cancer.

Learn more: https://www.eara.eu/news/why-age-worsens-breast-cancer-outcomes-insights-from-mice-and-humans

22/05/2026

The European Medicines Agency has recommended the authorisation of the first veterinary vaccine in the EU using RNA technology, designed to protect cats against five common infectious diseases, caused by feline herpesvirus, feline calicivirus, feline panleukopenia virus, Chlamydia felis and FeLV.

Learn more: https://www.eara.eu/news/ema-recommends-authorisation-of-first-rna-vaccine-for-cats

The European Medicines Agency (EMA) has recommended the authorisation of the first veterinary vaccine in the EU using RNA technology, designed to protect cats against five common infectious diseases, including feline leukaemia virus (FeLV). FeLV suppresses the immune system and is a common cause of....